Abstract Aims/hypothesis Unimolecular peptides targeting the receptors for glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP) and glucagon (GCG) have been shown to improve glycaemic management in both mice and humans
During a presentation at the American Association of Clinical Endocrinology Annual Scientific and Clinical Conference, Justin Do, DO, an endocrinology fellow at Loma Linda University Medical Center in California, said GLP-1s are not approved for the management of type 1 diabetes, but more people in that population are using the drugs for obesity treatment
Phospholipids: These are literally what your cell membranes are made of
BPC-157 10mg A 15-amino acid pentadecapeptide derived from human gastric juice, studied for its remarkable capacity to accelerate healing across musculoskeletal, gastrointestinal, and neural tissues
As we age or face environmental stressors, our DNA can incur damage
From there, researchers continued to push forward, eventually creating semaglutide